Engineering Stream


The State of the Science in Biotherapeutics Research and Development 

Antibody research in response to the COVID-19 pandemic has crash-tested new discovery technologies and caused the industry to find new ways of conducting discovery and development faster and more efficiently. With this as a foundation, the PEGS Engineering Stream examines the state of the science in biologics R&D, including smarter and higher throughput screening methods, new technologies to accelerate and optimize antibody engineering and the increasing role of machine learning in discovery and engineering. The Stream also explores developments in therapeutic antibodies for neurodegeneration, autoimmunity, cardiovascular disease and infectious diseases. Plan to join these essential tracks and see why PEGS has become the industry’s must-attend event in biotherapeutics R&D.


Conferences Include:

May 15-16

Display of Biologics

May 16-17

Engineering Antibodies

May 18-19

Machine Learning Approaches for Protein Engineering

Keynote Presentations:

Pirating Biology to Degrade Extracellular Proteins
James A. WellsJames A. Wells, PhD, Professor, Departments of Pharmaceutical Chemistry and Cellular & Molecular Pharmacology, University of California, San Francisco

Inhibition of Key Intracellular Targets via the Cytosolic Delivery of Antibodies and Proteins
Andrew TsourkasAndrew Tsourkas, PhD, Co-Director, Center for Targeted Therapeutics and Translational Nanomedicine; Professor, Bioengineering, University of Pennsylvania

Recent Advances in Protein Engineering
Regina BarzilayRegina Barzilay, PhD, Delta Electronics Professor, Electrical Engineering & Computer Science, Massachusetts Institute of Technology

Register Now

View By: